- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02080572
Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS
February 4, 2015 updated by: Great Lakes NeuroTechnologies Inc.
Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic.
Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are made in the clinic.
This study aims to quantitatively evaluate the effects of turning off deep brain stimulation on lower extremity and gait function over three hours.
This study will provide vital information about our patient worn system's ability to detect changes in lower impairment over time, which could be used to assist with DBS tuning for the lower extremities and gait in the future.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45220
- University of Cincinnati
-
Cleveland, Ohio, United States, 44106
- University Hospitals of Case Western
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Individuals with Parkinson's disease, gait impairment, and deep brain stimulation will be recruited.
Description
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson's disease
- Age > 21
- Underwent DBS surgery targeting the subthalamic nucleus (STN)
- Bilateral or midline involvement when "off" DBS/medication state
- Clinical history of gait impairment or freezing of gait
Exclusion Criteria:
- "Parkinson's plus" syndrome, secondary, or atypical Parkinson's disease
- Underwent DBS surgery targeting the ventral intermediate (VIM)
- Unable to walk independent of a wheelchair (use of assistive devices, like a cane, is okay for this study)
- Dementia (determined by a neuropsychological assessment).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Parkinson's Disease with DBS
Individuals with Parkinson's disease and deep brain stimulation will be recruited.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of DBS cessation on motor function over time
Time Frame: All data will be collected within a single session not to exceed 4 hours. All data will be analyzed within one month of study completion.
|
Motor function evaluations (movement speed and magnitude) will be collected at various time points after DBS cessation.
The effects over time will be examined.
|
All data will be collected within a single session not to exceed 4 hours. All data will be analyzed within one month of study completion.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Joseph P Giuffrida, PhD, Great Lakes NeuroTechnologies
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
March 4, 2014
First Submitted That Met QC Criteria
March 5, 2014
First Posted (Estimate)
March 6, 2014
Study Record Updates
Last Update Posted (Estimate)
February 5, 2015
Last Update Submitted That Met QC Criteria
February 4, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AG033947-03A1
- 2R44AG033947-03A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease With Deep Brain Stimulation
-
Rabin Medical CenterCompleted
-
Taipei Veterans General Hospital, TaiwanCompleted
-
China Medical University HospitalNational Science Council, TaiwanCompletedParkinson's Disease; Deep Brain StimulationTaiwan
-
Beijing Tiantan HospitalRecruitingDesflurane | Dexmedetomidine | Deep Brain Stimulation | PD - Parkinson's DiseaseChina
-
University of California, Los AngelesUniversity of California, San Diego; The Cleveland Clinic; University of California... and other collaboratorsCompletedParkinson's Disease Patients Undergoing Deep Brain Stimulation (DBS) SurgeryUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Enrolling by invitationDeep Brain StimulationUnited States
-
Surgical Information Sciences Inc.Terminated
-
Assistance Publique Hopitaux De MarseilleCompletedParkinson's Disease | With Inclusion Criteria for STN Deep Brain Stimulation | Presenting a Contraindication to Intracerebral Electrode ImplantatiFrance
-
The First Affiliated Hospital with Nanjing Medical...RecruitingDeep Brain Stimulation | Gastrointestinal MicrobiomeChina
-
Allegheny Singer Research Institute (also known...Boston Scientific CorporationRecruitingParkinson Disease | Deep Brain StimulationUnited States